Researchers

CHIBA Yasutaka

CHIBA Yasutaka
Associate Professor
Faculty Kindai University Hospital / Graduate School of Medical Sciences
Researchmap https://researchmap.jp/read0069849

Education and Career

Education

  • 京都大学大学院, 医学研究科,

Academic & Professional Experience

  • Apr. 2015 - Today , Kinki University Hospital Clinical Research Center Associate Professor
  • Apr. 2011 - Mar. 2015 , Kinki University School of Medicine Clinical Research Center Lecturer
  • Apr. 2008 - Mar. 2011 , Kinki University School of Medicine Environmental Medicine and Behavioral Science Assistant Professor
  • Mar. 2003 - Mar. 2008 , Kyoto University School of Public Health Department of Biostatistics Assistant Professor

Research Activities

Research Areas

  • Life sciences , Healthcare management, medical sociology
  • Life sciences , Hygiene and public health (non-laboratory)
  • Informatics , Statistical science

Research Interests

医療統計学, Epidemiology, Biostatistics

Published Papers

  1. Impact of B7-H3 and DLL3 expression on the efficacy of PD-L1 blockade therapy in extensive-stage small cell lung cancer.
    Takashi Kurosaki; Hiroaki Kanemura; Tomoyuki Otani; Yusuke Kawanaka; Yasushi Fukuda; Keita Kudo; Junko Tanizaki; Shinichiro Suzuki; Shuta Tomida; Kazuko Sakai; Yasutaka Chiba; Akihiko Ito; Kazuto Nishio; Kazuhiko Nakagawa; Hidetoshi Hayashi
    Lung cancer (Amsterdam, Netherlands)  207  , 108723-108723, Sep. 2025 
  2. Chromosomal Instability Is Associated with cGAS-STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung Cancer
    Kimio Yonesaka; Takashi Kurosaki; Junko Tanizaki; Hisato Kawakami; Kaoru Tanaka; Osamu Maenishi; Shiki Takamura; Kazuko Sakai; Yasutaka Chiba; Takeshi Teramura; Hiroki Goto; Eri Otsuka; Hiroaki Okida; Masanori Funabashi; Yuuri Hashimoto; Kenji Hirotani; Yasuki Kamai; Takashi Kagari; Kazuto Nishio; Kazuhiro Kakimi; Hidetoshi Hayashi
    CELLS  14  (6)  17, Mar. 2025 
  3. Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.
    Yoshihiko Fujita; Hiromichi Matsuoka; Yasutaka Chiba; Junji Tsurutani; Takeshi Yoshida; Kiyohiro Sakai; Miki Nakura; Ryo Sakamoto; Chihiro Makimura; Yoichi Ohtake; Kaoru Tanaka; Hidetoshi Hayashi; Takayuki Takahama; Junko Tanizaki; Atsuko Koyama; Kazuto Nishio; Kazuhiko Nakagawa
    Molecular and clinical oncology  22  (2)  , 14-14, Feb. 2025 

MORE

Books etc

  1. 「医療統計力」を鍛える! , 千葉 康敬 , 総合医学 , 2015

Conference Activities & Talks

  1. 結果変数が順序カテゴリカル変数のときのランダム化試験における因果効果のベイズ推測 , 千葉康敬 , 統計関連学会連合大会 , 10, Sep. 2020
  2. Inference of average causal effects in a randomized trial with a binary outcome , Chiba Y , The 2019 International Causal Inference Conference , May. 2019
  3. Bayesian inference of causal effects in randomized trials with a binary outcome , Chiba Y , The 29th International Biometric Conference , Jul. 2018

MORE

MISC

  1. Chromosomal instability leads to EGFR-TKI refractoriness via cGAS-STING activation in EGFR-mutated non-small cell lung cancer , Kimio Yonesaka; Takashi Kurosaki; Junko Tanizaki; Hisato Kawakami; Kaoru Tanaka; Osamu Maenishi; Shiki Takamura; Kazuko Sakai; Yasutaka Chiba; Takeshi Teramura; Hiroki Goto; Eri Otsuka; Hiroaki Okida; Masanori Funabashi; Yuuri Hashimoto; Kenji Hirotani; Yasuki Kamai; Takashi Kagari; Kazuto Nishio; Kazuhiro Kakimi; Hidetoshi Hayashi , CANCER RESEARCH , 85 , 8 , 15, Apr. 2025
  2. Final results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis , Masatoshi Kudo; Kazuomi Ueshima; Shin Nakahira; Naoshi Nishida; Hiroshi Ida; Yasunori Minami; Takuya Nakai; Hiroshi Wada; Shoji Kubo; Kazuyoshi Ohkawa; Asahiro Morishita; Takeo Nomi; Koji Ishida; Shogo Kobayashi; Makoto Umeda; Masakatsu Tsurusaki; Yasutaka Chiba; Kenichi Yoshimura; Kazuko Sakai; Kazuto Nishio , JOURNAL OF CLINICAL ONCOLOGY , 40 , 4 , Feb. 2022
  3. Adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis. , Masatoshi Kudo; Kazuomi Ueshima; Shin Nakahira; Naoshi Nishida; Hiroshi Ida; Yasunori Minami; Takuya Nakai; Hiroshi Wada; Shoji Kubo; Kazuyoshi Ohkawa; Asahiro Morishita; Takeo Nomi; Koji Ishida; Shogo Kobayashi; Makoto Umeda; Masakatsu Tsurusaki; Yasutaka Chiba; Kenichi Yoshimura; Kazuko Sakai; Kazuto Nishio , JOURNAL OF CLINICAL ONCOLOGY , 39 , 15 , May. 2021

MORE

Awards & Honors

  1. May. 2006, 日本計量生物学会, 奨励賞
  2. 近畿大学医学会賞, （2010年 - 2014年）

Research Grants & Projects

  1. 日本学術振興会, 科学研究費助成事業, 筋産生因子アイリシン低値はインスリン抵抗性と骨折リスクを高めるか－10年追跡研究 , 大阪医科薬科大学
  2. 文部科学省, 科学研究費補助金(基盤研究(C)), 因果推論の方法論に対応する正確な統計解析手法の開発
  3. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, The predictive ability of osteoporotic fractures for a risk of cardiovascular disease based on organ crosstalk :10-years follow-up of a cohort study for osteoporosis risk in men. , Osaka Medical College

MORE